Literature DB >> 21519721

Hospitalization rates for pneumococcal disease in Brazil, 2004 - 2006.

Hillegonda Maria Dutilh Novaes1, Ana Marli Christovam Sartori, Patricia Coelho de Soárez.   

Abstract

OBJECTIVE: To estimate hospitalization rates for pneumococcal disease based on the Brazilian Hospital Information System (SIH).
METHODS: Descriptive study based on the Hospital Information System of Brazilian National Health System data from January 2004 to December 2006: number of hospitalizations and deaths for pneumococcal meningitis, pneumococcal sepsis, pneumococcal pneumonia and Streptococcus pneumoniae as the cause of diseases reported in Brazil. Data from the 2003 Brazilian National Household Survey were used to estimate events in the private sector. Pneumococcal meningitis cases and deaths reported to the Notifiable Diseases Information System during the study period were also analyzed.
RESULTS: Pneumococcal disease accounted for 34,217 hospitalizations in the Brazilian National Health System (0.1% of all hospitalizations in the public sector). Pneumococcal pneumonia accounted for 64.8% of these hospitalizations. The age distribution of the estimated hospitalization rates for pneumococcal disease showed a "U"-shape curve with the highest rates seen in children under one (110 to 136.9 per 100,000 children annually). The highest hospital case-fatality rates were seen among the elderly, and for sepsis and meningitis.
CONCLUSIONS: PD is a major public health problem in Brazil. The analysis based on the SIH can provide an important input to pneumococcal disease surveillance and the impact assessment of immunization programs.

Entities:  

Mesh:

Year:  2011        PMID: 21519721     DOI: 10.1590/s0034-89102011005000028

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  10 in total

1.  Trends in Hospital Admission Rates and Associated Direct Healthcare Costs in Brazil: A Nationwide Retrospective Study between 2000 and 2015.

Authors:  Qi Zhao; Micheline S Z S Coelho; Shanshan Li; Paulo H N Saldiva; Michael J Abramson; Rachel R Huxley; Yuming Guo
Journal:  Innovation (Camb)       Date:  2020-04-25

2.  Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil.

Authors:  Patrícia Coelho de Soárez; Ana Marli Christovam Sartori; Angela Carvalho Freitas; Álvaro Mitsunori Nishikawa; Hillegonda Maria Dutilh Novaes
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

3.  Revisiting molecular serotyping of Streptococcus pneumoniae.

Authors:  Dhian R A Camargo; Fabiano S Pais; Ângela C Volpini; Marluce A A Oliveira; Roney S Coimbra
Journal:  BMC Genomics       Date:  2015-05-26       Impact factor: 3.969

4.  Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.

Authors:  Carmen Lucía Contreras; Jennifer R Verani; María Renee Lopez; Antonio Paredes; Chris Bernart; Fabiola Moscoso; Aleida Roldan; Wences Arvelo; Kim A Lindblade; John P McCracken
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

5.  Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.

Authors:  Sandra Rodrigues da Silva; Luane Marques de Mello; Anderson Soares da Silva; Altacílio Aparecido Nunes
Journal:  Rev Paul Pediatr       Date:  2016-03-30

6.  Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.

Authors:  Eliane Terezinha Afonso; Ruth Minamisava; Ana Luiza Bierrenbach; Juan Jose Cortez Escalante; Airlane Pereira Alencar; Carla Magda Domingues; Otaliba Libanio Morais-Neto; Cristiana Maria Toscano; Ana Lucia Andrade
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

7.  Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis.

Authors:  Leonam G Coutinho; Denis Grandgirard; Stephen L Leib; Lucymara F Agnez-Lima
Journal:  BMC Infect Dis       Date:  2013-07-17       Impact factor: 3.090

8.  Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.

Authors:  Johnna Perdrizet; Carlos Felipe S Santana; Thais Senna; Rodrigo Fernandes Alexandre; Rodrigo Sini de Almeida; Julia Spinardi; Matt Wasserman
Journal:  Hum Vaccin Immunother       Date:  2020-09-23       Impact factor: 3.452

9.  Clinical and microbiological implications of invasive pneumococcal disease in hospitalized patients (1998-2013).

Authors:  Silva Guerra; Marta Inês Cazentini Medeiros; Bento Vidal de Moura Negrini; Jorgete Maria E Silva; Samanta Cristine Grassi Almeida; Maria Luiza Leopoldo; Maria Luiza Leopoldo Silva Guerra; Denise de Andrade
Journal:  Braz J Infect Dis       Date:  2016-04-16       Impact factor: 3.257

10.  Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil.

Authors:  Carolina Regis Leite; Jailton Azevedo; Vivian Santos Galvão; Otávio Moreno-Carvalho; Joice Neves Reis; Cristiana Nascimento-Carvalho
Journal:  Braz J Infect Dis       Date:  2015-12-17       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.